← Back to Vaccine Database

Chimpanzee Adenovirus serotype 68 (ChAd) and self-amplifying mRNA (SAM) vectors expressing spike alone, or spike plus additional SARS-CoV-2 T cell epitopes.

Viral vector (Non-replicating) vaccine · VDDBV0153

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04776317 Phase 1COVID-19